The International Olympic Committee postpones the 2020 games slated for this summer; the American Society of Clinical Oncology (ASCO) urges Congress for increased protection and support for medical practices; AHIP will allow its member payers to transfer patients with coronavirus disease 2019 (COVID-19) from hospitals to other clinical settings, if appropriate, without prior authorization.
As reported in The New York Times, Prime Minister Shinzo Abe of Japan announced Tuesday that the International Olympic Committee (IOC) will postpone the Summer Games that had been scheduled to begin in Tokyo this July. The move comes after months of internal discussions and increased pressure from nations and athletes worldwide to reschedule the event amid the coronavirus disease 2019 (COVID-19) crisis. The event will now take place in the summer of 2021.
In a letter issued by the American Society of Clinical Oncology (ASCO), the organization urged the White House and Congress to work together to meet the needs of patients and healthcare professionals in response to the COVID-19 crisis. ASCO says 5 things need immediate action: increasing the availability of testing for patients and providers, increasing the availability of personal protective equipment, supporting physician practices to ensure uninterrupted patient access to care, supporting the use of telehealth, and implementing policies to address drug shortages.AHIP, a membership organization of health insurance providers, said its board of directors will allow hospitals and health systems to simplify and accelerate the transfer and discharge of patients who who have COVID-19 (or are presumed positive) from overwhelmed hospitals to other sites of care, such as home health, long-term acute care hospitals, or nursing homes, if clinically appropriate, without prior authorization. The organization also will match Medicare waivers to facilitate access to post-acute care. The moves are intended to help overwhelmed facilities increase capacity.
Switching to Gene Therapy After Nusinersen or Risdiplam May Benefit Patients With SMA
August 15th 2025Children with spinal muscular atrophy (SMA) showed motor function improvements after switching to onasemnogene abeparvovec following prior treatment with nusinersen or risdiplam in a real-world study.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More